Literature DB >> 18502379

Helix 3-helix 5 interactions in steroid hormone receptor function.

Junhui Zhang1, David S Geller.   

Abstract

Steroid hormones working through their receptors regulate a wide variety of physiologic processes necessary for normal homeostasis. Recent years have witnessed great advances in our understanding of how these hormones interact with their receptors, and have brought us closer to the era of directed drug design. We previously described a novel intramolecular interaction between helix 3 and helix 5 which is responsible for a Mendelian form of human hypertension. Further studies revealed that this interaction is highly conserved throughout the steroid hormone receptor family and functions as a key regulator of steroid hormone receptor sensitivity and specificity. Here, we review the contribution of helix 3-helix 5 interaction to steroid hormone receptor activity, with an eye towards how this knowledge may aid in the creation of novel therapeutic agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502379      PMCID: PMC2664652          DOI: 10.1016/j.jsbmb.2008.03.018

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  34 in total

1.  The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.

Authors:  Björn Kauppi; Clarissa Jakob; Mathias Färnegårdh; Jie Yang; Harri Ahola; Maria Alarcon; Karin Calles; Owe Engström; John Harlan; Steven Muchmore; Anna-Karin Ramqvist; Susanne Thorell; Lars Ohman; Jonathan Greer; Jan-Ake Gustafsson; Jan Carlstedt-Duke; Mats Carlquist
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

2.  Molecular basis of agonism and antagonism in the oestrogen receptor.

Authors:  A M Brzozowski; A C Pike; Z Dauter; R E Hubbard; T Bonn; O Engström; L Ohman; G L Greene; J A Gustafsson; M Carlquist
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

3.  Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities.

Authors:  V Vivat; D Gofflo; T Garcia; J M Wurtz; W Bourguet; D Philibert; H Gronemeyer
Journal:  J Mol Endocrinol       Date:  1997-04       Impact factor: 5.098

4.  Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.

Authors:  K E Weis; K Ekena; J A Thomas; G Lazennec; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1996-11

Review 5.  Steroid hormone receptors: many actors in search of a plot.

Authors:  M Beato; P Herrlich; G Schütz
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

6.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

7.  The molecular basis of RU486 resistance in the Tammar Wallaby, Macropus eugenii.

Authors:  S S Lim-Tio; M C Keightley; T P Fletcher; P J Fuller
Journal:  Mol Cell Endocrinol       Date:  1996-05-31       Impact factor: 4.102

8.  Hormone binding domain of human glucocorticoid receptor. Enhancement of transactivation function by substitution mutants M565R and A573Q.

Authors:  N Warriar; C Yu; M V Govindan
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

9.  Creation of "super" glucocorticoid receptors by point mutations in the steroid binding domain.

Authors:  P K Chakraborti; M J Garabedian; K R Yamamoto; S S Simons
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

10.  Cysteines 638 and 665 in the hormone binding domain of human glucocorticoid receptor define the specificity to glucocorticoids.

Authors:  C Yu; N Warriar; M V Govindan
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

View more
  2 in total

1.  A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule.

Authors:  Jérôme Fagart; Alexander Hillisch; Jessica Huyet; Lars Bärfacker; Michel Fay; Ulrich Pleiss; Elisabeth Pook; Stefan Schäfer; Marie-Edith Rafestin-Oblin; Peter Kolkhof
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

2.  Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.

Authors:  Larbi Amazit; Florian Le Billan; Peter Kolkhof; Khadija Lamribet; Say Viengchareun; Michel R Fay; Junaid A Khan; Alexander Hillisch; Marc Lombès; Marie-Edith Rafestin-Oblin; Jérôme Fagart
Journal:  J Biol Chem       Date:  2015-07-22       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.